FGF21 and metabolic dysfunction-associated steatotic liver disease: Dubosiella has been shown to ameliorate obesity (Ai et al., 2022), specifically regulated by FGF21, significantly improving liver function and reducing lipid accumulation in mice with NAFLD (Ye et al., 2023).